Recruiting Dravet Syndrome Studies in Birmingham
About Dravet Syndrome Clinical Trials in Birmingham
Dravet syndrome is a rare, severe form of epilepsy that begins in the first year of life with prolonged seizures often triggered by fever. It is usually caused by mutations in the SCN1A gene. Treatment includes specific antiseizure medications, avoiding certain drugs that can worsen seizures, and investigational gene therapies.
There are currently 1 dravet syndrome clinical trials recruiting participants in Birmingham, AL. These studies are seeking a combined 150 participants. Research is being sponsored by Epygenix. Clinical trial participation is free and participants receive study-related medical care at no cost.
Dravet Syndrome Clinical Trials in Birmingham — FAQ
Are there dravet syndrome clinical trials in Birmingham?
Yes, there are 1 dravet syndrome clinical trials currently recruiting in Birmingham, AL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Birmingham?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.
Are clinical trials in Birmingham free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.
What dravet syndrome treatments are being tested?
The 1 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for dravet syndrome.
Data updated October 12, 2026 from ClinicalTrials.gov